RussianPatents.com

Method for determining nuclear lens density. RU patent 2505812.

IPC classes for russian patent Method for determining nuclear lens density. RU patent 2505812. (RU 2505812):

G01N33/48 - Biological material, e.g. blood, urine (G01N0033020000-G01N0033140000, G01N0033260000, G01N0033440000, G01N0033460000 take precedence;determining the germinating capacity of seeds A01C0001020000); Haemocytometers (counting blood corpuscules distributed over a surface by scanning the surface G06M0011020000)
Another patents in same IPC classes:
Method for cellular analysis of probe by means of virtual analytical plate Method for cellular analysis of probe by means of virtual analytical plate / 2504777
Probe (2) is processed for cellular analysis. The above processing is intended for marking of pathologic cells among sound cells of a probe. Then, several pictures of probe (6) located on analytical plate (6) are taken to obtain a variety of pictures, each of which displays one zone of analytical plate (6). The above pictures located in a row form composite picture (20) of the sample. Besides, an automatic scrolling of all the taken pictures of sample (2) is performed on a display device at the pre-set scrolling speed. The above provided speed is such that an investigator can analyse a picture and determine whether the displayed sample zone contains potentially pathological cells or not; scrolling stops automatically at detection of an anomaly that can bear evidence of availability of a pathological cell.
Diagnostic technique for ischemic nephropathy in newborns Diagnostic technique for ischemic nephropathy in newborns / 2504776
Diagnosing of ischemic nephropathy in the newborns is ensured by diagnostic testing for 1-3 days of life according to anamnestic and biochemical findings, involving the determination of foetal age, sodium ion concentration, urine microalbumin, urine carbonic anhydrase to creatinine relation and blood free bilirubin concentration; that is followed by the calculation of a probability (P) of ischemic nephropathy by formula. If the value P is more than 50%, ischemic nephropathy is diagnosed in the newborns.
Method for assessing inducing action of cytomegalovirus infection on hemoglobin oxygenation in third trimester of gestation with underlying hemoglobin and 2,3-bisphosphoglycerate measurement in peripheral red blood cells Method for assessing inducing action of cytomegalovirus infection on hemoglobin oxygenation in third trimester of gestation with underlying hemoglobin and 2,3-bisphosphoglycerate measurement in peripheral red blood cells / 2504775
To assess a threatening hypoxia formation in the third trimester of gestation, peripheral blood is analysed for a cytomegalovirus antibody titre, peripheral blood 2,3-diphosphoglycerate, haemoglobun by cytophotometry, and peripheral blood oxyhaemoglobin. If observing an increase of the cytomegalovirus antibody titre to 1:1600, 2,3-diphosphoglycerate to 7.2 mcmole/ml, a decrease of hemoglobin to 72.25 standard units, a decrease of oxyhaemoglobin to 96.0%, the threatening hypoxia is expected.
Method for prediction of infectious inflammation of postoperative wound in external fixation of long bones / 2504774
Blood count is analysed, and a Calph-Caliph leucocytic intoxication index is calculated on the 3rd post-fracture day. If the derived value is 1.8 and more, the following external fixation is expected to be accompanied by the development of an infectious inflammation of the wound.
Method of predicting unfavourable course of locally spread forms of human papilloma virus-associated cervical cancer / 2504326
Invention relates to field of medicine, namely to oncogynecology. Immunological parameters are determined: absolute number of lymphocytes (lim_ab), TNFα (TNFα-k) and IL-10 (IL-IL10_k) in peripheral blood, as well as TNFα (TNFα-c) and IL-4 (IL-4_c) in cervical mucus. On the basis of obtained data parameter F(x) is calculated by formula: F(x): P(x)=9.265+1,749x(lim_ab)+0.013×(IL-4_c)+0.005×(IL-10_k)-0.410×(TNFα-k)-0.206×(TNPα-c). If value F(x) is higher than 0.555, unfavourable course of tumour process is predicted, in case if it is lower than 0.555, favourable course is predicted.
Method for assessing conditions of proliferative cervical diseases Method for assessing conditions of proliferative cervical diseases / 2503960
Method is staged: 1) cervical canal scrapes and biopsy materials of the uterine cervix are used to recover DNA of human papilloma virus; 2) virus genotype is determined; 3) patients with HPV 16 positive CIN are sampled; 4) real-time PCR is used to determine the number of virus DNA copies and a degree of its integration with a host gene (a physical status); 5) a threshold level of the viral load is stated taking into account the physical status of the virus (6.5 lg HPV DNA copies 16 per one cell); 6) the patients are classified according to the determined threshold viral load and physical status of the virus (the episomal and integrated form); 7) the poorly predicted patients having the high viral load (≥6.5 lg DNA copies per one cell) are detected in the episomal form of the virus, while the low load (<6.5 lg DNA copies per one cell) is shown by the integrated form of the virus.
Method for prediction of individual risk of bronchial asthma in regions with high and low incidence of helminth infections / 2503959
Presence or absence of opisthorchiasis is stated; and polymorphous versions of genes and a possibility of referring an individual to a group with a low or high risk of bronchial asthma are found. If observing one of any risk combinations in accordance with the SOCS5-IFNG-opisthorchiasis model in the patient, the high risk of bronchial asthma is diagnosed. If observing one of any protective combinations in accordance with the IL4-TBX21-SOCS5 model in the patient, the low risk of bronchial asthma is diagnosed.
Method of individual quantitative assessment of ischemic heart disease development Method of individual quantitative assessment of ischemic heart disease development / 2503405
Invention relates to cardiology, pathophysiology, biochemistry and pharmacology. To assess development of ischemic heart disease value of discriminant function is calculated by a set of parameters: age, height, weight, Quetelet index, Broca's index, abdominal obesity, triglycerides, total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, atherogenicity index, arterial pressure, glucose, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, α-amilase, total protein, albumin, uric acid, urea, creatinine, creatine kinase, alkaline phosphatase, total bilirubin, direct bilirubin, ADP-induced platelet aggregation, collagen-induced platelet aggregation, platelet number, mean platelet volume, number of red blood cells, hematocrit, hemoglobin, mean corpuscular volume, RDW-CV, average content of hemoglobin in blood, number of white blood cells, percent content of neutrophil granulocytes, percent content of eosinophils, percent content of basophils, percent content of lymphocytes, percent content of monocytes, mean content of hemoglobin on red blood cell. Conclusion about initial stage of IHD development, 50% risk of disease or 100% development of IHD is made on the basis of obtained value.
Method for assessing disturbance of transamination in plasmodiotrophoblast in third trimester of pregnancy in aggravated herpes viral infection by histochemical method of pyridoxalphosphate dehydrogenase activity in placental plasmodiotrophoblast Method for assessing disturbance of transamination in plasmodiotrophoblast in third trimester of pregnancy in aggravated herpes viral infection by histochemical method of pyridoxalphosphate dehydrogenase activity in placental plasmodiotrophoblast / 2503007
Histochemical method is used to assess pyridoxalphosphate dehydrogenase activity. The disturbance of transamination in placental plasmodiotrophoblast is shown by herpes virus antibody titre 1:12800 and decreased pyridoxalphosphate dehydrogenase activity below 12.5±0.37 standard units that is presented in the form of an increase of transaminase to 0.58±0.002 mmole/l in placental homogenate.
Differential diagnostic technique for haemorrhagic and ischemic strokes Differential diagnostic technique for haemorrhagic and ischemic strokes / 2503002
What is presented is differential diagnostic technique for acute haemorrhagic and ischemic strokes. The amount of low-molecular DNA fraction is specified by comparing 24-hour electrophoretogram from patient's blood plasma to the standard known concentrations. If the amount of low-molecular DNA 3 hours after the onset of acute stroke is 80-87 ng/ml, haemorrhage stroke is diagnosed. If the amount of low-molecular DNA 24 hours after the onset of acute stroke is 80-87 ng/ml, ischemic stroke is diagnosed.
Method for predicting hallucino-delirious forms of psychoses of cerebro-atherosclerotic genesis / 2244303
One should isolate DNA out of lymphocytes of peripheral venous blood, then due to the method of polymerase chain reaction of DNA synthesis one should amplify the fragments of hSERT locus of serotonin carrier gene and at detecting genotype 12/10 one should predict the risk for the development of hallucino-delirious forms of psychoses of cerebro-atherosclerotic genesis.
Method for predicting prostatic tuberculosis Method for predicting prostatic tuberculosis / 2244513
One should conduct subcutaneous prevocational tuberculin test and, additionally, both before the test and 48 h later it is necessary to perform the mapping of prostatic vessels and at decreased values of hemodynamics one should diagnose tuberculosis. The information obtained should be documented due to printing dopplerograms.
Device and method for extracting nucleic acids Device and method for extracting nucleic acids / 2244559
The suggested innovation deals with the fact that nucleic acids should be isolated directly out of the sample without pipetting stage but with the help of interconnected reservoirs being prepared beforehand. The above-mentioned vessels should be applied either separately or being interconnected according to standard microtitrating format. The sample should be mixed with a lyzing buffer and nucleic acids are bound with matrix in closed system including, at least, two interconnected reservoirs. Forced movement of sample's mixture and buffer back and forth from one reservoir into another one for several times through narrow passage provides their thorough intermixing. The method provides quick and safe isolation of nucleic acids.
Method for assay of medicinal sensitivity of tuberculosis mycobacterium / 2244927
Diagnostic material is poured preliminary with chlorohexidine bigluconium solution, homogenized, kept at room temperature for 10-12 h and centrifuged. Precipitate is poured with Shkolnikova's liquid medium, incubated at 37oC for 3 days, supernatant part of Shkolnokova's medium is removed, fresh Shkolnikova's medium is added, and precipitate is stirred and inoculated on the dense cellular egg media. Sensitivity of the strain is determined in 3 weeks by the presence of growth in the control tube only. Invention provides enhancing precision and reducing time for assay. Invention can be used in assay for medicinal sensitivity of tuberculosis mycobacterium.
Endogenic pharmaceutical composition prepared on basis of goal-seeking activation of humoral mediators of brain cortex nerve ending Endogenic pharmaceutical composition prepared on basis of goal-seeking activation of humoral mediators of brain cortex nerve ending / 2244928
Invention relates to agents used for treatment of pathological states associated with disorder of synthesis of neuromediating substances. Method involves the development of pharmaceutical composition and a method for it preparing. Pharmaceutical composition represents subcellular synaptosomal fractions: synaptic membranes, "light" synaptosomes and "heavy" synaptosomes prepared from gray matter of cerebral hemispheres from experimental animals based on the goal-seeking modification of humoral mediators of nerve endings transformed to synaptosomes in development and regression of malignant processes. The composition provides inhibiting the growth of tumor cells, to elevate span-life of patients with ascite Ehrlich's sarcoma, breast adenocarcinoma Ca-755, Wolker's carcinosarcoma-256.
Method for estimating treatment effectiveness in atherosclerotic lower extremity ischemia patients Method for estimating treatment effectiveness in atherosclerotic lower extremity ischemia patients / 2244929
Method involves carrying out microscopic examination of blood serum samples taken from femoral vein and cubital vein. Femoral vein sample is taken on injured side. The examination is carried out before and after treatment. The blood serum samples are placed on fat-free glass slide in the amount of 0.01-0.02 ml as drops, dried at 18-30°C for 18-24 h. The set of pathological symptoms becoming larger or not changed after the treatment in comparison to sample taken before treatment, and morphological picture of samples under comparison taken from the cubital vein showing no changes or being changed to worse, the treatment is considered to be effective.
Method for predicting the result of acute peroral intoxication with cauterizing liquids Method for predicting the result of acute peroral intoxication with cauterizing liquids / 2244930
At patient's hospitalization one should gather the data of clinical and laboratory values: on the type of chemical substance, patient's age, data of clinical survey and laboratory values: body temperature, the presence or absence of dysphonia, oliguria being below 30 ml/h, hemoglobinuria, erythrocytic hemolysis, exotoxic shock, glucose level in blood, fibrinogen and creatinine concentration in blood serum, general bilirubin, prothrombin index (PTI), Ph-plasma, the state of blood clotting system. The state of every sign should be evaluated in points to be then summed up and at exceeding the sum of points being above "+20" one should predict unfavorable result. At the sum of "-13" prediction should be stated upon as favorable and at "-13" up to "+20" - prediction is considered to be doubtful.
Method for detecting disease duration in children with chronic obstructive pyelonephritis (variants) Method for detecting disease duration in children with chronic obstructive pyelonephritis (variants) / 2245548
Disease duration in case of obstructive pyelonephritis should be detected by two ways: either by detecting the value of NADPH-diaphorase activity, as the marker of nitroxide synthase activity in different renal department and comparing it to established norm, or by detecting clinico-laboratory values, such as: hemoglobin, leukocytes, eosinophils, urea, beta-lipoproteides, lymphocytes, neutrophils, the level of glomerular filtration, that of canalicular reabsorption, urinary specific weight, daily excretion of oxalates, arterial pressure, and estimating their deviation against average statistical values by taking into account a child's age.
Method for predicting prostatic cancer Method for predicting prostatic cancer / 2245549
The present innovation deals with differential diagnostics of prostatic cancer and other prostatic diseases at the stage of primary inspection. The method includes the detection of PCA and calculation of probability coefficient for prostatic cancer (PCC) by the following formula: where e - the foundation of natural logarithm (e=2.718…), PCA - the level of total blood PCA in ng/ml, V - patient's age in years. At PCC value being above 0.2 one should diagnose prostatic cancer and to establish final diagnosis one should perform polyfocal prostatic biopsy. The method enables to increase accuracy of diagnostics at decreased number of unjustified prostatic biopsies.
Nutrient medium for accumulation of cell sample for following cytological and/or immunocytochemical analysis / 2246110
Invention relates to nutrient medium used for accumulation of cells for the following cytological and/or immunocytochemical analysis carrying out. Invention relates to medium containing salts NaCl, KCl, anhydrous CaCl2, MgSO4 x 6 H2O, MgCl2 x 6 H2O, Na2HPO4 x 2 H2O, KHPO4, NaHCO3, and also glucose and Henx's solution, 10% albumin solution and polyglucin taken in the ratio 1:1:1. Invention provides enhancing the preservation of cells.

FIELD: medicine.

SUBSTANCE: patient's venous blood serum is analysed for vascular endothelial growth factor (VEGF). If the derived values in the patients suffering type 1 diabetes mellitus is 141-187 pg/ml, degree 1 and very low nuclear lens density are diagnosed; the value of 188-234 pg/ml enables diagnosing degree 2 and low nuclear lens density; and the value of 235-280 pg/ml shows degree 3 and moderate nuclear lens density. In the patients suffering type 2 diabetes mellitus, the VEGF value of 281-330 pg/ml provides diagnosing degree 2 and low nuclear lens density; the derived value of 331-382 pg/ml shows degree 3 and moderate nuclear lens density; if the value is 383-432 pg/ml, degree 4 and high nuclear lens density are diagnosed; the respective value of 433-478 pg/ml provides diagnosing degree 5 and very high nuclear lens density. In the patients diagnosed with no diabetes mellitus, the VEGF value of 290-336 pg/ml ensures diagnosing degree 2 and low nuclear lens density; the value of 337-379 pg/ml provides degree 3 and moderate nuclear lens density; if the value is 380-426 pg/ml, degree 4 and high nuclear lens density are diagnosed; the derived value of 427-465 pg/ml provides diagnosing degree 5 and very high nuclear lens density.

EFFECT: invention provides performing a phacoemulsification using the sparing ultrasound parameters that minimises its impact on the eyeball tissues and reduces a risk of the related postoperative complications in the patients suffering diabetes mellitus.

2 tbl, 2 ex

 

The present invention relates to medicine, in particular to ophthalmology, and can be used for choosing the most optimal method of cataract surgery. The developed method for accurate preoperative determine the density of the nucleus of the lens allows phacoemulsification using sparing ultrasound characteristics that allows to minimize its impact on the tissues eyeball patterns, and reduce the risk of associated complications in the postoperative period in patients with diabetes and get higher functional results in the postoperative period. With the purpose of optimization of surgical treatment method selection of adequate crushing the nucleus of the lens is reasonable estimation of the density of the nucleus of the lens.

The only effective method of cataract treatment is surgical. The primary method of surgical treatment of cataract today is phacoemulsification with intraocular lens, but its implementation in patients with diabetes is associated with increased risk of complications and inefficiency of conservative therapy of multiple complications in intra - and postoperative periods, which makes the actual optimization of phacoemulsification of cataract patients with diabetes mellitus. The use of excessive ultrasound characteristics of these patients it would be not only unnecessary, but potentially harmful influence of ultrasound on the structure of the eye, including cornea, vascular sheath and retina. This is due to concomitant diseases of the retina associated with diabetes. Use of mainly torsion ultrasound technology OZil on surgical system "Infiniti" ("Alcon") when phacoemulsification cataract allows to reduce time of influence of ultrasound of the eye tissue. This reduces the intensity of post-operative swelling of the cornea, and thus leads to more quickly reach possible visual acuity in the postoperative period.

There is a method of intraoperative determine the density of the nucleus of the lens, which consists in the determination and registration of the human lens materials peaks with the help of ultrasonic study of the eye, wherein the initially estimated height and determine the number of additional human lens materials peaks, and then during the operation instrument, containing its working surface division, jam on the front cortical layers of the natural lens to the moment of his bias on the bundle, if the number of tick marks on a working surface of the tool, sunken in front cortical layers, more than 4, the height of additional lenticular peak less than half the height of the main front lenticular peak, the number of additional human lens materials peaks less than 4, then make a conclusion about the low density of the lens (Nazarenko G.B. Interbranch scientific-technical complex "eye microsurgery").

However, this technique is invasive and is not precise enough. He is accompanied by higher risk, which can lead to complications during surgery. When pressed on the lens, especially if there is a defect lens ligaments possible damage to the ligaments, until lens, vitreous. Also there may be a mechanical trauma of the corneal endothelium as a result of additional intraocular manipulation.

There is a method of determining the density of the nucleus of the lens, ultrasound media of the eye (Friedman .., R.A., MB Ultrasound in ophthalmology. - M: Medicine, 1989, 256 C.).

However, the real biological media (in this case, cataract lens) is markedly heterogeneous and has a resonant, and other properties which strongly distorts the echo. This fact does not allow sufficiently accurately only on data of ultrasound echography interpret cataract lens in his physical density.

To date, the most widely for determining the density of the lens used method Emery J. and Little J. (1979), based on the colorimetric characteristics of the lens.

However, this method is subjective and is not precise enough.

We first developed a way of exact preoperative determine the density of the nucleus of the lens on the index of venous blood.

Survey of 220 patients with cataracts (220 eye): the core group of -1 20 patients with diabetes mellitus (120 eyes), and of these 11 patients with diabetic cataracts (11 eyes) - group 1, 109 - age cataract (109 eyes) against diabetes - 2 group, the control group of 100 patients with age cataract without diabetes (100 patients). All patients received standard ophthalmologic examination. In blood serum of all patients the study of levels of vascular endothelial growth factor (VEGF). He is the stimulator of the migration of endothelial cells from deep layers of the retina, vitreous activation of angiogenesis, cell proliferation, causing increase in vascular permeability, hypertrophy of endothelial cells, leading to narrowing of blood vessels, reducing blood flow and increasing hypoxia. The study was performed in the blood obtained from the cubital vein. Blood samples was performed in patients on an empty stomach in the morning. With the aim of standardizing used tubes for blood collection «Vacuette». For the study of VEGF in blood serum tubes used with activator coagulation (silica) and separating gel, forming a barrier between the serum and coagulating blood after centrifugation.

Microsurgical treatment of cataract patients was conducted: the method of ultrasonic phacoemulsification. Ultrasonic phacoemulsification was conducted using a surgical system "Infiniti" ("Alcon") by standard methods. In the course of the operations registered at the equivalent time ultrasound spent for the fragmentation of the lens. Density cataract was estimated according to the classification J. Emery and Little J. (1979), based on the colorimetric characteristics of the lens of the eye (5 levels density: 1 degree - lens light gray in color, visible fundus of the eye reflex, fundus of the eye , soft core, low density, 2 - the lens is light yellow, fundus of the eye reflex sight, fundus of the eye , soft core, low density, 3 - lens-intensive yellow color with brownish tint, fundus not , moderately dense core, the average density of 4 - lens brown, fundus of the eye reflex is not defined, the fundus not , dense core, a high degree, 5 - the lens of dark-brown color, fundus of the eye reflex is not visible, fundus not , hard core, a very high degree.

Table 1.

The average density of the nucleus of the lens on a scale J. Emery and Little J. (1979) (points)

The density of the nucleus of the lens in groups

Age

up to 20 years

21-40 years

41-50 years

51-60

61-70 years

71-80 years

81-90 years

Group 1 (patients with type 1 DM)

1 2 3 - - - -

Group 2 (patients with type 2 diabetes)

- - 2 3 4 5 -

Control group

- - - 2 3 4 5

In the early postoperative period analyzed equivalent time of influence of ultrasound, its capacity and condition of the cornea in various forms of cataract. All the patients underwent morphological, immunocytochemical and immunohistochemical studies capsules and substance of the lens of the human eye with the use of standard methods of coloring to determine the expression of a- (α-A and a-C), beta-, gamma . The dependence of the density of the lens from the age increases as age increases the density of the lens) and presence of diabetes (diabetes mellitus lens density less than that of patients with age cataract in the same age group).

The content of the growth factor in the blood serum of patients with DM and without it, depending on the degree of density of a cataract is presented in the table.

Table 2.

The content of the growth factor in the blood serum of patients with DM and without it, depending on the degree of density of cataract

The group surveyed

degree Density

VEGF PG/ml

Norm

Up to 140

Group 1 (patients with type 1 DM) (20 years)

1 very low 141-187

Group 1 (patients with type 1 DM) (21-40 years)

2 low 188-234

Group 1 (patients with type 1 DM) (41-50 years)

3 moderate 235-280

Group 2 patients with T2DM) (41-50 years)

2 low 281-330

Group 2 (patients with type 2 diabetes)

3 moderate 331-382 (51-60)

Group 2 patients with T2DM) (61-70 years)

4 high 383-432

Group 2 patients with T2DM) (71-80 years)

5

very high

433-478

The control group (patients without DM) (51-60)

2 low 290-336

The control group (patients without DM) (61-70 years)

3 moderate 337-379

The control group (patients without DM) (71-80 years)

4 high 380-426

The control group (patients without DM) (81 to 90 years)

5

very high

427-465

Thus, patients with type 1 DM, at the value of the serum VEGF - 141-187 PG/ml = 1 degree and very low density of the nucleus of the lens. Patients suffering from type 1 DM, at the value of the serum VEGF - 188-234 PG/ml corresponds to 2 degrees and the low density of the nucleus of the lens. Patients suffering from type 1 DM, at the value of the serum VEGF - 235-280 PG/ml = 3 extent and moderate density of the nucleus of the lens. In patients with type 2 diabetes, at the value of the serum VEGF - 281-330 PG/ml corresponds to 2 degrees and the low density of the nucleus of the lens. In patients with type 2 diabetes, at the value of the serum VEGF - 331-382 PG/ml = 3 extent and moderate density of the nucleus of the lens. In patients with type 2 diabetes, at the value of the serum VEGF - 383-432-189 PG/ml corresponds to 4 degrees and high density of the nucleus of the lens. In patients with type 2 diabetes, at the value of the serum VEGF - 433-478 PG/ml equivalent to 5 degrees and a very high density of the nucleus of the lens. Patients of the control group without diabetes, at the value of the serum VEGF - 290-336 PG/ml corresponds to 2 degrees and the low density of the nucleus of the lens. Patients of the control group without diabetes, serum VEGF - 337-379 PG/ml = 3 extent and moderate density of the nucleus of the lens. Patients of the control group without diabetes, at the value of the serum VEGF - 380-426 PG/ml corresponds to 4 degrees and high density of the nucleus of the lens. Patients of the control group without diabetes, at the value of the serum VEGF - 427-465 PG/ml equivalent to 5 degrees and a very high density of the nucleus of the lens.

At 1-2 degrees and very low and low density of the nucleus of the lens more effective in terms of reducing the time of influence of ultrasound and its power (in the sum of «dose» of ultrasound technique of «Chip and Flip», «Karusel» and similar. With 3 degrees and moderate density of the nucleus of the lens - «Phaco-Chop», «Stop and Dispute» and such. At 4 degrees and high density of the nucleus of the lens - «Divide and Conquer». At 5 degrees and a very high density of the lens is recommended to remove cataracts method of extracapsular extraction. Phacoemulsification in this case is not desirable because of the possible trauma of all structures of the eye high power ultrasound and long time of its use during the operation. Lower density of the nucleus of the lens in patients with cataracts against diabetes, associated with the peculiarities of crystallin composition of these patients are allowed to conduct the phacoemulsification with the lower energy parameters, as a rule, using primarily torsion ultrasound. Taking into account these features allowed us to perform a phacoemulsification using sparing ultrasound characteristics, which allowed to minimize its impact on the tissues eyeball patterns, and reduce the risk of associated complications in the postoperative period in patients with diabetes and get higher functional results.

Example 1. The patient A., 72 years old, not a suffering diabetes, the study of venous blood serum value of VEGF amounted to 386 PG/ml This level of VEGF corresponds to 4 degrees and high density of the nucleus of the lens. Given the high degree of density of nucleus of the lens, was chosen method of splitting the kernel «Divide and Conquer». For this case study is the most effective and least traumatic for all structures of the eye method. In the course of the operation really the core of the lens was quite hard. Placed us the extent and density of the lens on the number in the venous blood of VEGF coincides with the degree and density of the lens by the method of J. Emery and Little J. Phacoemulsification was carried out without complications and already in the early postoperative period was achieved high functional result.

Example 2. The patient A., 50 years old, suffering from type 2 diabetes, the study of venous blood serum value of VEGF amounted to 342 PG/ml This level of VEGF corresponds to 2 degrees of density of the nucleus of the lens. Placed us the extent and density of the lens on the number in the venous blood of VEGF coincides with the degree and density of the lens by the method of J. Emery and Little J. Given the low density, gentle enough nucleus of the lens, was chosen method of crushing kernel «carousel». For this clinical case this is the most suitable method. Phacoemulsification was carried out without complications and already in the early postoperative period was achieved high functional result.

The method of preoperative determine the density of the nucleus of the lens, which consists in that the patient serum of venous blood to determine the vascular endothelial growth factor and its importance in patients with type 1 diabetes, 141-187 PG/ml diagnose 1 degree and a very low density of the nucleus of the lens, at value - 188-234 PG/ml diagnose 2 degree and a low density of nucleus of the lens, at value - 235-280 PG/ml are diagnosed in stage 3 and moderate density of the nucleus of the lens, patients with type 2 diabetes, a value - 281-330 PG/ml diagnose 2 degree and a low density of nucleus of the lens, at value - 331-382 PG/ml are diagnosed in stage 3 and moderate density of the nucleus of the lens, at value - 383-432 PG/ml diagnose 4 degree and a high density of nucleus of the lens, at value - 433-478 PG/ml are diagnosed in 5 degree and a very high density of nucleus of the lens, in patients without diabetes, a value - 290-336 PG/ml diagnose 2 degree and a low density of nucleus of the lens, at value - 337-379 PG/ml are diagnosed in stage 3 and moderate density of the nucleus of the lens when the value - 380-426 PG/ml diagnose 4 degree and a high density of nucleus of the lens, at value - 427-465 PG/ml are diagnosed in 5 degree and a very high density of nucleus of the lens.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.